830 related articles for article (PubMed ID: 17296173)
1. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
Cakmak A; Soker M; Koc A; Erel O
J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263
[TBL] [Abstract][Full Text] [Related]
3. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.
Selek S; Cosar N; Kocyigit A; Erel O; Aksoy N; Gencer M; Gunak F; Aslan M
Clin Biochem; 2008 Feb; 41(3):140-4. PubMed ID: 18154731
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase-1 and oxidative status in common Mediterranean β-thalassaemia mutations trait, and their relations to atherosclerosis.
Labib HA; Etewa RL; Gaber OA; Atfy M; Mostafa TM; Barsoum I
J Clin Pathol; 2011 May; 64(5):437-42. PubMed ID: 21427447
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
8. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
9. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
[TBL] [Abstract][Full Text] [Related]
11. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
[TBL] [Abstract][Full Text] [Related]
12. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
15. Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities.
Karikas GA; Schulpis KH; Bartzeliotou A; Regoutas S; Thanopoulou C; Papaevangelou V; Giannoulia-Karantana A; Papassotiriou I; Fytou-Pallikari A
Scand J Clin Lab Invest; 2009; 69(1):31-5. PubMed ID: 19016076
[TBL] [Abstract][Full Text] [Related]
16. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women.
Verit FF; Celik H; Yazgan P; Erel O; Geyikli I
Arch Gynecol Obstet; 2007 May; 275(5):353-9. PubMed ID: 17086419
[TBL] [Abstract][Full Text] [Related]
19. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
20. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
